These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35175490)

  • 1. Ten-year follow-up of cardiac resynchronization therapy patients with non-ischemic dilated cardiomyopathy assessed by radionuclide angiography: a single-center cohort study.
    Valzania C; Massaro G; Spadotto A; Muraglia L; Frisoni J; Martignani C; Ziacchi M; Diemberger I; Fanti S; Boriani G; Biffi M; Galié N
    J Interv Card Electrophysiol; 2022 Sep; 64(3):723-731. PubMed ID: 35175490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of cardiac mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy in patients with non-ischaemic dilated cardiomyopathy using equilibrium radionuclide angiography.
    Mukherjee A; Patel CD; Naik N; Sharma G; Roy A
    Europace; 2016 Jun; 18(6):851-7. PubMed ID: 26056184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization.
    de Sisti A; Toussaint JF; Lavergne T; Ollitrault J; Abergel E; Paziaud O; Ait Said M; Sader R; LE Heuzey JY; Guize L
    Pacing Clin Electrophysiol; 2005 Dec; 28(12):1260-70. PubMed ID: 16403157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cardiac resynchronization therapy on right ventricular function during rest and exercise, as assessed by radionuclide angiography, and on NT-proBNP levels.
    Valzania C; Biffi M; Bonfiglioli R; Fallani F; Martignani C; Diemberger I; Ziacchi M; Frisoni J; Tomasi L; Fanti S; Rapezzi C; Boriani G
    J Nucl Cardiol; 2019 Feb; 26(1):123-132. PubMed ID: 28667454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
    McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
    Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure.
    Qiu Q; Chen YX; Mai JT; Yuan WL; Wei YL; Liu YM; Yang L; Wang JF
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):329-37. PubMed ID: 25392055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Equilibrium Radionuclide Angiogram-Derived Measures of Dyssynchrony to Predict Outcomes in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy.
    Badhwar N; James J; Hoffmayer KS; O'Connell JW; Green D; De Marco T; Botvinick EH
    J Nucl Med; 2016 Dec; 57(12):1880-1886. PubMed ID: 27417646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of mechanical dyssynchrony as assessed by radionuclide ventriculography to predict the cardiac resynchronization therapy response.
    Tournoux F; Chequer R; Sroussi M; Hyafil F; Algalarrondo V; Cohen-Solal A; Bodson-Clermont P; Le Guludec D; Rouzet F
    Eur Heart J Cardiovasc Imaging; 2016 Nov; 17(11):1250-1258. PubMed ID: 26613747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of equilibrium radionuclide angiography to predict acute response to cardiac resynchronization therapy in patients with heart failure.
    Chen Y; Yan J; Zhao S; Long Q; Wang H; Wang L
    Nucl Med Commun; 2015 Jun; 36(6):610-8. PubMed ID: 25759945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy.
    Adelstein EC; Schwartzman D; Jain S; Bazaz R; Wang NC; Saba S
    Europace; 2017 Oct; 19(10):1689-1694. PubMed ID: 27856539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of super-response to cardiac resynchronization therapy.
    Rohit MK; Krishnappa D
    Indian Heart J; 2019; 71(4):334-337. PubMed ID: 31779862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of cardiac mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy in patients with nonischaemic dilated cardiomyopathy using gated myocardial perfusion SPECT.
    Mukherjee A; Patel CD; Naik N; Sharma G; Roy A
    Nucl Med Commun; 2015 May; 36(5):494-501. PubMed ID: 25695610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of left ventricular function under cardiac resynchronization therapy goes along with a reduced incidence of ventricular arrhythmia.
    Eickholt C; Siekiera M; Kirmanoglou K; Rodenbeck A; Heussen N; Schauerte P; Lichtenberg A; Balzer J; Rassaf T; Perings S; Kelm M; Shin DI; Meyer C
    PLoS One; 2012; 7(11):e48926. PubMed ID: 23152822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of right ventricular myocardial contractility on the response to cardiac resynchronization therapy].
    Lebedev DI; Popov SV; Mishkina AI; Lebedeva MV
    Kardiologiia; 2018 SFeb; (S2):19-24. PubMed ID: 29782250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy.
    D'Andrea A; Salerno G; Scarafile R; Riegler L; Gravino R; Castaldo F; Cocchia R; Limongelli G; Romano M; Calabrò P; Nigro G; Cuomo S; Bossone E; Caso P; Calabrò R
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1017-29. PubMed ID: 19659622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.
    Bleeker GB; Mollema SA; Holman ER; Van de Veire N; Ypenburg C; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    Circulation; 2007 Sep; 116(13):1440-8. PubMed ID: 17785624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy.
    Molhoek SG; Bax JJ; van Erven L; Bootsma M; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    Am J Cardiol; 2004 Apr; 93(7):860-3. PubMed ID: 15050489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QRS duration shortening predicts left ventricular reverse remodelling in patients with dilated cardiomyopathy after cardiac resynchronization therapy.
    Zhang J; Zhang Y; Zhou X; Li J; Li Y; Zhang Y; Xu G; Xing Q; Lin S; Tang B
    Acta Cardiol; 2015 Jun; 70(3):307-13. PubMed ID: 26226704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.
    Kutyifa V; Geller L; Bogyi P; Zima E; Aktas MK; Ozcan EE; Becker D; Nagy VK; Kosztin A; Szilagyi S; Merkely B
    Eur J Heart Fail; 2014 Dec; 16(12):1323-30. PubMed ID: 25379962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.